A New Sildenafil Oral Film in Patients With Erectile Dysfunction

PHASE3CompletedINTERVENTIONAL
Enrollment

488

Participants

Timeline

Start Date

January 26, 2024

Primary Completion Date

December 9, 2024

Study Completion Date

December 9, 2024

Conditions
Erectile Dysfunction
Interventions
DRUG

Sildenafil Oral Film 25 mg, 50 mg, 75 mg or 100 mg

Sildenafil Oral Film containing 25 mg, 50 mg, 75 mg or 100 mg sildenafil as citrate, flexible-dose

DRUG

Placebo

Placebo Oral Film

Trial Locations (18)

11530

AccuMed Research Associates, Garden City

14609

Rochester Clinical Research, Inc, Rochester

23235

Virginia Urology, Richmond

33135

Clintex Research Group, Miami

33157

Innovation Clinical Trials: Medical Reseach Center, Palmetto Bay

33162

Harmony Clinical Research, North Miami Beach

33186

Coral Research Clinic, Miami

33316

Innovation Medical Group LLC (Endo Care of South Florida), Fort Lauderdale

33351

Precision Clinical Research, LLC, Sunrise

35801

Medical Affiliated Research Center, Huntsville

36535

G & L Research LLC., Foley

37909

Alliance for Multispeciaty Research, LLC, Knoxville

72211

Arkansas Urology Research Center, Little Rock

77479

Mt. Olympus Medical Research Group, LLC, Sugar Land

77598

Tranquil Clinical and Research Consulting Services, LLC, Webster

89119

Alliance for Multispecialty Research, LLC, Las Vegas

90017

Urology Group of Southern California, Los Angeles

92562

Tri Valley Urology Medical Group, Murrieta

Sponsors
All Listed Sponsors
lead

IBSA Institut Biochimique SA

INDUSTRY

NCT05490680 - A New Sildenafil Oral Film in Patients With Erectile Dysfunction | Biotech Hunter | Biotech Hunter